Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers
Abstract Background The identification of appropriate biomarkers is essential to support important clinical decisions in patients with prostate cancer. The aim of our study was a systematic bioinformatical analysis of the mRNA expression of all genes available for the prostate adenocarcinoma cohort...
Main Authors: | Anika Kremer, Tobias Kremer, Glen Kristiansen, Yuri Tolkach |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12894-019-0479-z |
Similar Items
-
Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer
by: Shiyong Gao, et al.
Published: (2021-07-01) -
Limitations of Explainability for Established Prognostic Biomarkers of Prostate Cancer
by: Kalifa Manjang, et al.
Published: (2021-07-01) -
Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies
by: Tomas Bertok, et al.
Published: (2020-10-01) -
Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
by: Eun-Wie Cho
Published: (2012-12-01) -
Adrenomedullin Is a Diagnostic and Prognostic Biomarker for Acute Intracerebral Hemorrhage
by: Francisco J. Julián-Villaverde, et al.
Published: (2021-06-01)